Efficacy and safety of tolcapone in levodopa-treated Parkinson's disease patients with “wearing-off” phenomenon: a multicentre, double-blind, randomized, placebo-controlled trial

V. V. Myllylä; M. Jackson; J. P. Larsen; H. Baas;

doi:10.1111/j.1468-1331.1997.tb00358.x

Efficacy and safety of tolcapone in levodopa-treated Parkinson's disease patients with “wearing-off” phenomenon: a multicentre, double-blind, randomized, placebo-controlled trial

European Journal of Neurology ◽

10.1111/j.1468-1331.1997.tb00358.x ◽

1997 ◽

Vol 4 (4) ◽

pp. 333-341 ◽

Cited By ~ 24

Author(s):

V. V. Myllylä ◽

M. Jackson ◽

J. P. Larsen ◽

H. Baas ◽

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Wearing Off

Download Full-text

Efficacy and safety of istradefylline in moderate to severe Parkinson’s disease: A phase 3, multinational, randomized, double-blind, placebo-controlled trial (i-step study)

Journal of the Neurological Sciences ◽

10.1016/j.jns.2017.08.999 ◽

2017 ◽

Vol 381 ◽

pp. 351-352 ◽

Cited By ~ 1

Author(s):

S. Isaacson ◽

K. Eggert ◽

R. Kumar ◽

F. Stocchi ◽

A. Mori ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Step Study

Download Full-text

Efficacy and safety of adjunctive rasagiline in Japanese Parkinson's disease patients with wearing-off phenomena: A phase 2/3, randomized, double-blind, placebo-controlled, multicenter study

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2018.04.025 ◽

2018 ◽

Vol 53 ◽

pp. 21-27 ◽

Cited By ~ 4

Author(s):

Nobutaka Hattori ◽

Atsushi Takeda ◽

Shinichi Takeda ◽

Akira Nishimura ◽

Masafumi Kato ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicenter Study ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Wearing Off

Download Full-text

Faculty Opinions recommendation of TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1058963.510919 ◽

2007 ◽

Author(s):

Pascal Derkinderen

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Double Blind ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8286956.8718054 ◽

2011 ◽

Author(s):

Irene Litvan ◽

Rita Simoes

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Depressive Symptoms ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8638956.9139058 ◽

2011 ◽

Cited By ~ 1

Author(s):

John O'Brien ◽

John-Paul Taylor

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Dementia With Lewy Bodies ◽

Controlled Trial ◽

Lewy Bodies ◽

Parkinson’S Disease Dementia ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Pingchan granule for depressive symptoms in parkinson’s disease: A randomized, double-blind, placebo-controlled trial

Journal of Integrative Medicine ◽

10.1016/j.joim.2020.12.006 ◽

2020 ◽

Author(s):

Si-chun Gu ◽

Jie Zhou ◽

Qing Ye ◽

Can-xing Yuan

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Depressive Symptoms ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double‐blind, randomized placebo‐controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study)

Neurourology and Urodynamics ◽

10.1002/nau.24552 ◽

2021 ◽

Author(s):

Sung Yong Cho ◽

Seong Jin Jeong ◽

Sangchul Lee ◽

Janghwan Kim ◽

Seong Ho Lee ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(10)70254-4 ◽

2010 ◽

Vol 9 (12) ◽

pp. 1164-1172 ◽

Cited By ~ 405

Author(s):

William J Marks ◽

Raymond T Bartus ◽

Joao Siffert ◽

Charles S Davis ◽

Andres Lozano ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomised Controlled Trial ◽

Gene Delivery ◽

Controlled Trial ◽

Double Blind ◽

Randomised Controlled

Download Full-text

Efficacy and safety of foslevodopa/foscarbidopa versus oral carbidopa/levodopa in advanced Parkinson's disease patients: Design of a phase 3, randomized, double-blind, double-dummy, active controlled 12-week trial

Journal of the Neurological Sciences ◽

10.1016/j.jns.2021.119569 ◽

2021 ◽

Vol 429 ◽

pp. 119569

Author(s):

Maurizio Facheris ◽

Weining Robieson ◽

Nahome Fisseha ◽

David Standaert

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Advanced Parkinson’S Disease

Download Full-text

Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson’s disease

BMC Neurology ◽

10.1186/s12883-015-0312-6 ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 16

Author(s):

Nicolien M van der Kolk ◽

Sebastiaan Overeem ◽

Nienke M de Vries ◽

Roy PC Kessels ◽

Rogier Donders ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Randomized Controlled Trial ◽

Phase Ii ◽

Controlled Trial ◽

Motor Symptoms ◽

Double Blind ◽

Randomized Controlled ◽

Non Motor Symptoms

Download Full-text